Suchergebnisse - Xinhui Chen
- Treffer 1 - 11 von 11
-
1
-
2
-
3
An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis von Song Zhu, Jizhong Wang, De Chen, Yutian He, Nan Meng, Min Chen, Ruixun Lu, Xinhui Chen, Xiaolan Zhang, Guang‐Rong Yan
Veröffentlicht 2020Artigo -
4
-
5
Long-read sequencing revealed complex biallelic pentanucleotide repeat expansions in RFC1-related Parkinson’s disease von Peng Liu, Fan Zhang, Xinhui Chen, Xiaosheng Zheng, Miao Chen, Zhiru Lin, Shuqi Chen, Lebo Wang, Xinchen Wang, Nan Jin, Chenxin Ying, Fei Xie, Bo Wang, Sheng Wu, Zhidong Cen, Wei Luo
Veröffentlicht 2025Artigo -
6
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid... von Sarina A. Piha‐Paul, Ravit Geva, Tira J. Tan, Wan‐Teck Lim, Cinta Hierro, Toshikiko Doi, Osama E. Rahma, Alexander M. Lesokhin, Jason J. Luke, J. Otero, Lisa Nardi, Angad Singh, Alexandros Xyrafas, Xinhui Chen, Jennifer Mataraza, Philippe L. Bédard
Veröffentlicht 2021Artigo -
7
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas von Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi, Wells A. Messersmith, Robert H.I. Andtbacka, Matthew Ingham, Nancy Lewis, Xinhui Chen, Marc R. Pelletier, Xueying Chen, Jincheng Wu, Thomas W. Dubensky, Sarah M. McWhirter, Thomas Müller, Nitya Nair, Jason J. Luke
Veröffentlicht 2021Artigo -
8
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study von Funda Meric‐Bernstam, Randy F. Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia, Reinhard Dummer, Agostina Stradella, Georgina V. Long, Anna Spreafico, Toshio Shimizu, Neeltje Steeghs, Jason J. Luke, Sarah M. McWhirter, Thomas Müller, Nitya Nair, Nancy Lewis, Xinhui Chen, Andrew Bean, Lisa Kattenhorn, Marc R. Pelletier, Shahneen Sandhu
Veröffentlicht 2022Artigo -
9
SLC7A11 is an unconventional H+ transporter in lysosomes von Nan Zhou, Jingzhi Chen, Meiqin Hu, Na Wen, Weijie Cai, Ping Li, Liding Zhao, Yaping Meng, Zhao Dongdong, Xiaotong Yang, Siyu Liu, Fangqian Huang, Cheng Zhao, Xinghua Feng, Zikai Jiang, Enjun Xie, Hongxu Pan, Zhidong Cen, Xinhui Chen, Wei Luo, Beisha Tang, Junxia Min, Fudi Wang, Junsheng Yang, Haoxing Xu
Veröffentlicht 2025Artigo -
10
Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State von Sharon M. Seifert, Xinhui Chen, Amie L. Meditz, José Castillo‐Mancilla, Edward M. Gardner, Julie A. Predhomme, Carolyn Clayton, Gregory L. Austin, Brent E. Palmer, Jia‐Hua Zheng, Brandon Klein, Becky Jo Kerr, Louis Guida, Caitlin Rower, Joseph E. Rower, Jennifer J. Kiser, Lane R. Bushman, Samantha MaWhinney, Peter L. Anderson
Veröffentlicht 2016Artigo -
11
Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification von Zhidong Cen, You Chen, Si Chen, Hong Wang, Dehao Yang, Hongmei Zhang, Hongwei Wu, Lebo Wang, Siyang Tang, Jia Ye, Jian Shen, Haotian Wang, Feng Fu, Xinhui Chen, Fei Xie, Peng Liu, Xuan Xu, Jianzhi Cao, Pan Cai, Qinqing Pan, Jieying Li, Wei Yang, Peng‐Fei Shan, Yuezhou Li, Jingyu Liu, Baorong Zhang, Wei Luo
Veröffentlicht 2019Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Biology
Medicine
Gene
Biochemistry
Genetics
Internal medicine
Pharmacokinetics
Adverse effect
Cell biology
Gastroenterology
Immunology
Oncology
Cancer
Carcinogenesis
Computational biology
Molecular biology
Neuroscience
Pathology
Pharmacodynamics
Pharmacology
Protein subunit
Tolerability
Acetylation
Acetyltransferase
Aerospace engineering
Agonist
AlkB
Andrology
Antiretroviral therapy
Arthritis